ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.60
-0.34%
US Tech 100
17,650.00
0.05%
S&P 500
5,222.68
0.16%
US Dollar vs CAD
1.36775
0.00%
Bitcoin
60,991.52
0.32%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cingulate Inc (CINGW)

  7. Cingulate Inc (CINGW) News

CINGW Cingulate Inc

0.0218
0.0002 (0.93%)
May 10 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cingulate Inc CINGW NASDAQ Equity Warrant
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.0002 0.93% 0.0218 15:00:02
Open Price Low Price High Price Close Price Previous Close
0.0218 0.0218 0.0218 0.0218 0.0216
more quote information »

Recent News

Date Time Source Heading
5/08/202406:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/08/202406:10EDGAR2Form 8-K - Current report
5/08/202406:00GLOBECingulate Reports First Quarter 2024 Financial Results and..
4/30/202404:45GLOBEPeter J. Werth, Successful Pharma Entrepreneur,..
4/16/202416:00GLOBECingulate to Participate in Planet MicroCap Showcase: Vegas..
4/01/202407:00GLOBECingulate Inc. Reports Fourth Quarter and Full Year 2023..
3/19/202415:45GLOBECingulate to Participate in Benzinga All Live Access Event
3/06/202405:45GLOBECingulate to Attend DCAT Week 2024 in New York City
2/13/202405:45GLOBECingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff..
2/06/202415:15GLOBECingulate Announces Closing of $7.5 Million Public Offering
2/02/202408:15GLOBECingulate Announces Pricing of $7.5 Million Public Offering
1/29/202407:00GLOBELongtime Cingulate Controller Jennifer Callahan Promoted to..
1/29/202405:45GLOBEWerth Family Investment Associates Converts Remaining $3.3M..
12/01/202308:00GLOBECingulate Receives Guidance from FDA on Path Forward for..
11/13/202315:15GLOBECingulate Inc. Reports Third Quarter 2023 Financial..
10/17/202313:22GLOBECingulate to Host CNS Key Opinion Leader Panel in New York..
9/21/202312:30GLOBECingulate Inc. to Present at the LD Micro Main Event XVI
9/13/202315:15GLOBECingulate Announces Closing of $4.0 Million Public Offering
9/11/202308:22GLOBECingulate Announces Pricing of $4.0 Million Public Offering
9/11/202305:00GLOBECingulate Announces Detailed Trial Results from Phase 3..
9/08/202315:31GLOBEWerth Family Investment Associates Converts $5.8 Million of..
9/05/202307:00GLOBECingulate Announces Presentation of Full Trial Results from..
8/14/202315:15GLOBECingulate Inc. Reports Second Quarter 2023 Financial..
7/11/202307:00GLOBECingulate Announces Positive Top-Line Results from Phase 3..
6/29/202307:00GLOBECingulate Successfully Manufactures Clinical Supply –..
6/14/202314:45GLOBECingulate to Participate in the Healthcare Virtual..
6/08/202306:00GLOBECingulate Completes Phase 3 Adult Trial of CTx-1301..
5/25/202314:55GLOBECingulate to Present at 13th Annual LD Micro Invitational

Your Recent History

NASDAQ
CINGW
Cingulate
BOV
BBSEQ305
BBSEQ305 Ex:30,64
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved